USPSTF Recommends Screening Adults for Unhealthy Alcohol Use
By Elana Gotkine HealthDay Reporter

TUESDAY, Aug. 5, 2025 -- The U.S. Preventive Services Task Force (USPSTF) recommends screening adults for unhealthy alcohol use and providing brief behavioral counseling interventions for those engaged in risky drinking. These recommendations form the basis of a draft recommendation statement published online Aug. 5.
Researchers examined evidence on the benefits and harms of screening and interventions to identify and reduce unhealthy alcohol use. Data were obtained from one stepped-wedge randomized controlled trial (RCT) on the benefits of screening among pregnant women, 15 diagnostic accuracy studies, and 84 RCTs of interventions to reduce unhealthy alcohol use (five involving adolescents; 79 involving adults). The researchers found no differences in alcohol consumption in the trial of screening. Use of several brief screeners was supported by diagnostic accuracy studies for identifying youth with alcohol use disorder. In a pooled analysis of RCTs conducted among adults to test interventions to reduce alcohol use, those in the intervention groups reduced alcohol consumption more than those in control groups.
Based on these findings, the USPSTF recommends screening adults aged 18 years or older for unhealthy alcohol use in primary care settings and providing brief behavioral counseling interventions to reduce unhealthy alcohol use for those engaged in risky or hazardous drinking (B recommendation). For adolescents aged 12 to 17 years, the current evidence is insufficient to assess the balance of benefits and harms of screening and brief behavioral counseling interventions (I statement).
“While adolescent alcohol use is a serious concern, there is not enough evidence to determine whether or not screening and counseling in primary care helps to reduce alcohol use in teens, so we are calling for more research,” USPSTF member John Ruiz, Ph.D., from the University of Arizona in Tucson, said in a statement. “In the absence of evidence, health care professionals should use their judgment when determining whether or not to screen their teen patients.”
The draft recommendation statement and draft evidence review have been posted for public comment. Comments can be submitted through Sept. 2, 2025.
Draft Recommendation Statement
Comment on Recommendation Statement
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-08-06 06:00
Read more

- Popular YoCrunch Yogurt Recalled Over Plastic Pieces in Packaging
- Planned C-Section May Be Tied to Increased Risk for Leukemia in Offspring
- Obstructive Sleep Apnea Tied to Poor Outcomes in U.S. Soldiers
- FDA Approves Vizz (aceclidine ophthalmic solution) for the Treatment of Presbyopia
- FDA Approves Sephience (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria
- Excess Weight Increases Risk of Health Double-Whammy Among Older Women
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions